Literature DB >> 27222753

Fabrication of electrospun nanofibres of BCS II drug for enhanced dissolution and permeation across skin.

Ravindra N Kamble1, Sheetal Gaikwad1, Akhil Maske1, Sharvil S Patil1.   

Abstract

The present work reports preparation of irbesartan (IBS) loaded nanofibre mats using electrospinning technique. The prepared nanofibres were characterized by scanning electron microscopy, Fourier transform infrared spectroscopy, differential scanning calorimetry, X-ray diffraction analysis, in vitro diffusion and ex vivo skin permeation studies. FTIR studies revealed chemical compatibility of IBS and polyvinyl pyrrolidine (PVP K-30). SEM images confirmed formation of nanofibres wherein IBS existed in amorphous form as revealed by DSC and XRD analyses. The prepared nanofibre mats of IBS were found to be superior to IBS loaded as cast films when analysed for in vitro IBS release and ex vivo skin permeation studies since the flux of IBS loaded nanofibres was 17 times greater than as cast film. The improvement in drug delivery kinetics of IBS loaded nanofibres could be attributed to amorphization with reduction in particle size of IBS, dispersion of IBS at molecular level in PVP matrix and enormous increase in the surface area for IBS release due to nanonization. Thus transdermal patch of IBS loaded nanofibres can be considered as an alternative dosage form in order to improve its biopharmaceutical properties and enhance therapeutic efficacy in hypertension.

Entities:  

Keywords:  Electrospinning; Irbesartan; Nanofibres; Polyvinyl pyrrolidone; Skin permeation; Transdermal drug delivery

Year:  2016        PMID: 27222753      PMCID: PMC4856818          DOI: 10.1016/j.jare.2016.03.009

Source DB:  PubMed          Journal:  J Adv Res        ISSN: 2090-1224            Impact factor:   10.479


  13 in total

1.  Statistical assessment of dissolution and drug release profile similarity using a model-dependent approach.

Authors:  Mark R Berry; Michael D Likar
Journal:  J Pharm Biomed Anal       Date:  2007-05-25       Impact factor: 3.935

Review 2.  Transdermal drug delivery in vitro using diffusion cells.

Authors:  L Bartosova; J Bajgar
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

3.  Analysis of Fickian and non-Fickian drug release from polymers.

Authors:  N A Peppas
Journal:  Pharm Acta Helv       Date:  1985

Review 4.  The new angiotensin II receptor antagonist, irbesartan: pharmacokinetic and pharmacodynamic considerations.

Authors:  H R Brunner
Journal:  Am J Hypertens       Date:  1997-12       Impact factor: 2.689

5.  Liquid crystalline phase as a probe for crystal engineering of lactose: carrier for pulmonary drug delivery.

Authors:  Sharvil S Patil; Kakasaheb R Mahadik; Anant R Paradkar
Journal:  Eur J Pharm Sci       Date:  2014-11-22       Impact factor: 4.384

Review 6.  Irbesartan. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in the management of hypertension.

Authors:  J C Gillis; A Markham
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

7.  Preformulation study of the inclusion complex irbesartan-beta-cyclodextrin.

Authors:  Rajashree Hirlekar; Vilasrao Kadam
Journal:  AAPS PharmSciTech       Date:  2009-03-13       Impact factor: 3.246

8.  Utility of a transdermal delivery system for antihypertensive therapy. Part 1.

Authors:  D A Sclar; T L Skaer; A Chin; M P Okamoto; M A Gill
Journal:  Am J Med       Date:  1991-07-18       Impact factor: 4.965

9.  Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods.

Authors:  S Sethia; E Squillante
Journal:  Int J Pharm       Date:  2004-03-19       Impact factor: 5.875

10.  Formulation and development of a self-nanoemulsifying drug delivery system of irbesartan.

Authors:  Jaydeep Patel; Anjali Patel; Mihir Raval; Navin Sheth
Journal:  J Adv Pharm Technol Res       Date:  2011-01
View more
  7 in total

1.  Preparation and Evaluation of Polyvinylpyrrolidone Electrospun Nanofiber Patches of Pioglitazone for the Treatment of Atopic Dermatitis.

Authors:  Rana Obaidat; Ayat Abu Shameh; Mohannad Aljarrah; Rania Hamed
Journal:  AAPS PharmSciTech       Date:  2022-01-10       Impact factor: 3.246

2.  Preparation, optimization, and in vitro-in vivo evaluation of sorafenib-loaded polycaprolactone and cellulose acetate nanofibers for the treatment of cutaneous leishmaniasis.

Authors:  Mahsa Alemomen; Somayeh Taymouri; Sedigheh Saberi; Jaleh Varshosaz
Journal:  Drug Deliv Transl Res       Date:  2022-10-12       Impact factor: 5.671

3.  The Delivery of the Novel Drug 'Halicin' Using Electrospun Fibers for the Treatment of Pressure Ulcer against Pathogenic Bacteria.

Authors:  Walaa S Aburayan; Rayan Y Booq; Nouf S BinSaleh; Haya A Alfassam; Abrar A Bakr; Haitham A Bukhary; Essam J Alyamani; Essam A Tawfik
Journal:  Pharmaceutics       Date:  2020-12-08       Impact factor: 6.321

Review 4.  Electrospun nanofibers: A nanotechnological approach for drug delivery and dissolution optimization in poorly water-soluble drugs.

Authors:  Luis Castillo-Henríquez; Rolando Vargas-Zúñiga; Jorge Pacheco-Molina; Jose Vega-Baudrit
Journal:  ADMET DMPK       Date:  2020-07-05

5.  Melittin from Bee Venom Encapsulating Electrospun Fibers as a Potential Antimicrobial Wound Dressing Patches for Skin Infections.

Authors:  Walaa S Aburayan; Areej M Alajmi; Ahmed J Alfahad; Wijdan K Alsharif; Abdullah A Alshehri; Rayan Y Booq; Samar A Alsudir; Fatemah M Alsulaihem; Haitham A Bukhary; Moutaz Y Badr; Essam J Alyamani; Essam A Tawfik
Journal:  Pharmaceutics       Date:  2022-03-28       Impact factor: 6.525

6.  Dry Formulation of Virus-Like Particles in Electrospun Nanofibers.

Authors:  Sasheen Dowlath; Katrin Campbell; Farah Al-Barwani; Vivienne L Young; Sarah L Young; Greg F Walker; Vernon K Ward
Journal:  Vaccines (Basel)       Date:  2021-03-03

7.  Cyclodextrin Complexed Lipid Nanoparticles of Irbesartan for Oral Applications: Design, Development, and In Vitro Characterization.

Authors:  Narendar Dudhipala; Swetha Ettireddy; Ahmed Adel Ali Youssef; Goverdhan Puchchakayala
Journal:  Molecules       Date:  2021-12-13       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.